Sexual dysfunction associated with the treatment of depression: A placebo-controlled comparison of bupropion sustained release and sertraline treatment

Annals of Clinical Psychiatry

Volumn 11, Issue 4, 1999, Pages 205-215

  Coleman, Charles C ^a,d   Cunningham, Lynn A ^b   Foster, Vicki J ^c   Batey, Sharyn R ^c   Donahue, Rafe M J ^c   Houser, Trisha L ^c   Ascher, John A ^c  

^a Mississippi Neuropsychiatric Clinic   (United States)

^b Glaxo Wellcome Inc ^*  (United States)

^c GLAXOSMITHKLINE   (United States)

^d Paragon Center   (United States)

Author keywords

Antidepressants; Bupropion sustained release; Depression; Sertraline; Sexual dysfunction

Indexed keywords

AMFEBUTAMONE; PLACEBO; SERTRALINE;

ADULT; AGED; AGITATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; ORGASM; PREMATURE EJACULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SEXUAL AROUSAL; SEXUAL DYSFUNCTION; SUSTAINED RELEASE PREPARATION; WEIGHT REDUCTION; XEROSTOMIA;

EID: 0032706420     PISSN: 10401237     EISSN: None     Source Type: Journal    
DOI: 10.3109/10401239909147072     Document Type: Article

References (42)

1. Settle EC: Managing antidepressant side effects. Drug Ther 1993; 23(7):17-30
2. Pollack MH, Rosenbaum JF: Management of antidepressant-induced side effects: a practical guide for the clinician. J Clin Psychiatry 1987; 48:3-8
3. Mitchell JE, Popkin MK: Antidepressant drug therapy and sexual dysfunction in men: a review. J Clin Psychopharmacol 1983; 3:76-79
4. DeLeo D, Magni G: Sexual side effects of antidepressant drugs. Psychosomatics 1983; 24:1076-1082
5. Herman, JB, Brotman AW, Pollack MH, Falk WE, Biederman J, Rosenbaum JF: Fluoxetine-induced sexual dysfunction. J Clin Psychiatry 1990; 51:25-27
6. Segraves RT: Overview of sexual dysfunction complicating the treatment of depression. J Clin Psychiatry Monogr 1992; 10:4-10
7. Hopkins HS: Antidotes for depression-induced sexual dysfunction. Biol Ther Psychiatry 1992; 15:33-36
8. Jacobsen FM: Fluoxetine-induced sexual dysfunction in an open trial of yohimbine. J Clin Psychiatry 1992; 53:119-122
9. Nitenson NC, Cole JO: Psychotropic-induced sexual dysfunction. In: Dunner DL, ed. Current Psychiatric Therapy. Philadelphia: Saunders; 1993:353-359
10. 2a/2c and α2 antagonist, in the treatment of sexual dysfunction induced by serotonin reuptake inhibitors. Clin Neuropharmacol 1997; 20(3):210-214
11. Zajecka J, Fawcett J, Schaff M, Jeffriess H, Guy C: The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction. J Clin Psychiatry 1991; 52:66-68
12. Sovner R: Treatment of tricyclic antidepressant-induced orgasmic inhibition with cyproheptadine. J Clin Psychopharmacol 1984; 4:169
13. Reimherr FW, Chouinard G, Cohn CK, Cole JO, Itil TM, LaPierre YD, Masco HL, Mendels J: Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatry 1990; 51:18-27
14. Cohn CK, Shrivastava R, Mendels J, Cohn JB, Fabre LR, Claghorn JL, Dessain EC, Itil TM, Lautin A: Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry 1990; 51:28-33
15. Doogan DP, Caillard V: Sertraline: a new antidepressant. J Clin Psychiatry 1988; 49(suppl 8):46-51
16. Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS: Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry 1996; 57(suppl 2):53-62
17. Segraves RT, Kavoussi R, Hughes AR, Batey SR, Johnston JA, Donahue R, Ascher JA: Evaluation of sexual functioning in depressed outpatients: a double-blind comparison of bupropion sustained release and sertraline treatment. J Clin Psychopharmacol 1999 (in press)
18. Gitlin MJ: Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches. J Clin Psychiatry 1994; 55:406-413
19. Kavoussi RJ, Segraves RT, Hughes AR, Ascher JA, Johnston JA: Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients. J Clin Psychiatry 1997; 58:532-537
20. Reimherr FW, Cunningham LA, Batey SR, Johnston JA, Ascher J A: A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients. Clin Ther 1998; 20:505-516
21. Ascher JA, Cole JO, Colin J, Feighner JP, Ferris RM, Fibiger HC, Golden RN, Martin P, Potter WZ, Richelson E, Sulser F: Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 1995; 56:395-401
22. Ferris RM, Cooper BR: Mechanism of antidepressant activity of bupropion. J Clin Psychiatry Monograph 1993; 11(1):2-14
23. Gardner EA, Johnston JA: Bupropion: an antidepressant without sexual pathophysiological action. J Clin Psychopharmacol 1985; 5:24-29
24. Modell JG, Katholi CR, Modell JD, DePalma RL: Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline. Clin Pharmacol Ther 1997; 61:476-487
25. Croft H, Settle E, Houser T, Batey SR, Donahue RMJ, Ascher JA: A placebo-controlled comparison of the antidepressant and sexual functioning effects of bupropion sustained release and sertraline. Clin Ther 1999; 21(4):643-658.
26. American Psychiatric Association: Mood Disorders. In: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Revised. Washington, DC: American Psychiatric Association, 1994:317-345
27. Hamilton M: A rating scale for depression. J Neurol Neurologic Psychiatry 1960; 23:56-62
28. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychiatry 1967; 6:278-296
29. Graham CA, Ramos R, Bancroft J, Maglaya C, Farley TMM: The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods. Contraception 1995; 52:363-369
30. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959; 50-55
31. Guy W: ECDEU Assessment Manual for Psychopharmacology. US Dept. of Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health; 1976; 218-222
32. Salazar WH: Management of depression in the outpatient office. Med Clin North Am 1996; 80(2):431-455
33. McElroy SL, Keck PE, Friedman LM: Minimizing and managing antidepressant side effects. J Clin Psychiatry 1995; 56(suppl 2):49-55
34. Wise TN: A model for the assessment of sexual dysfunction etiology. J Clin Psychiatry Monograph 1992; 10(2):5-18
35. Sertraline (ZOLOFT®) Product Information. Pfizer Inc., 1997
36. Fabre LF, Abuzzahab FS, Amin M, Claghorn JL, Mendels J, Petrie WM, Dube S, Small JG: Sertraline safety and efficacy in major depression: a double-blind fixed dose comparison with placebo. Biol Psychiatry 1995; 38:592-602
37. Hsu JH, Shen WW: Male sexual side effects associated with antidepressants: a descriptive clinical study of 32 patients. Int J Psychiatry Med 1995; 25(2):191-201
38. Harvey KV, Balon R: Clinical implications of antidepressant drug effects on sexual function. Ann Clin Psych 1995; 7(4): 189-201
39. Murdoch D, McTavish D: Sertraline: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder. Drugs 1992; 44:604-624
40. Balon R: Drug holidays to counter sexual dysfunction. Am J Psychiatry 1996; 153(10):1370-1371
41. Rothschild AJ: Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday. Am J Psychiatry 1995; 152:1514-1516
42. Zajecka J, Tracy K, Mitchell S: Discontinuation symptoms following treatment with serotonin reuptake inhibitors; a literature review. J Clin Psychiatry 1997; 58(7):291-297